Abstract
Christine Ellingsen, Stefan Walenta, Tord Hompland, Wolfgang Mueller-Klieser, Einar K. Rofstad
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Management of early and locally advanced cervical cancer
10.1053/j.seminoncol.2008.12.007 · 2009
Locally advanced cervical cancer: what is the standard of care?
10.1097/cco.0b013e32833af426 · 2010
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
2005
Biological predictors of cervical cancer response to radiation therapy
10.1016/j.semradonc.2011.12.009 · 2012
Biological consequences of tumor hypoxia
10.1016/s0093-7754(01)90211-8 · 2001
Blood flow and associated pathophysiology of uterine cervix cancers: characterisation and relevance for localised hyperthermia
10.3109/02656736.2012.699134 · 2012
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
10.1016/0167-8140(93)90025-4 · 1993
Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
1996
Oxygenation predicts radiation response and survival in patients with cervix cancer
10.1016/s0167-8140(98)00044-9 · 1998
Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization
10.1016/s0167-8140(99)00175-9 · 2000
Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements
2001
Long-term performance of interstitial fluid pressure and hypoxia as prognostic factors in cervix cancer
10.1016/j.radonc.2006.07.014 · 2006
Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy
10.1158/1078-0432.ccr-09-0560 · 2009
Correlation of high lactate levels in human cervical cancer with incidence of metastasis
1995
High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers
2000
MRI of the tumor microenvironment
10.1002/jmri.10181 · 2002
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
10.1200/jco.2006.06.8080 · 2006
Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy
10.1016/s1470-2045(06)71012-9 · 2007
Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer
10.1097/rli.0b013e3181a64ce9 · 2009
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome
1998
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix
10.1038/sj.bjc.6605415 · 2010
Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer
10.1016/j.ijrobp.2008.09.050 · 2009
Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance
10.1016/j.ijrobp.2011.05.050 · 2012
Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging
10.1002/jmri.10016 · 2001
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement
1997
Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix
10.1016/s0167-8140(00)00259-0 · 2000
Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors
10.1007/s00432-009-0558-8 · 2009
Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging
10.1016/j.radonc.2010.12.016 · 2011
Dynamic contrast-enhanced MRI of tumor hypoxia
10.1002/mrm.23014 · 2012
Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI
10.1002/mrm.1910310516 · 1994
Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts
10.1002/mrm.20149 · 2004
Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols
10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · 1999
A simple method for measuring interstitial fluid pressure in cancer tissues
10.1016/j.mvr.2005.07.003 · 2005
Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours
10.1080/095530099139250 · 1999
Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis
10.1158/1078-0432.ccr-06-1967 · 2007
Metabolic mapping with bioluminescence: basic and clinical relevance
10.1016/s1389-0344(01)00107-1 · 2002
Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology
10.2174/0929867043364711 · 2004
A bioluminescence technique for quantitative and structure-associated imaging of pyruvate
10.1038/labinvest.3700493 · 2007
Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging
10.1007/bf00157805 · 1993
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
10.1073/pnas.0709747104 · 2007
Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype
10.1158/1078-0432.ccr-11-0397 · doi-reference
Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI
10.1158/0008-5472.can-12-0903 · doi-reference
Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T
10.1002/nbm.2804 · doi-reference
Lymphangiogenesis and cancer metastasis
10.1111/j.1582-4934.2009.00834.x · doi-reference
A driving force for change: interstitial flow as a morphoregulator
10.1016/j.tcb.2006.11.007 · doi-reference
Lactate: a metabolic key player in cancer
10.1158/0008-5472.can-11-1457 · doi-reference
Hypoxia, gene expression, and metastasis
10.1007/s10555-007-9063-1 · doi-reference
The tumor microenvironment and metastatic disease
10.1007/s10585-008-9182-2 · doi-reference
Microenvironment-induced cancer metastasis
10.1080/095530000138259 · doi-reference
Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia
10.1002/ijc.23449 · doi-reference
Lactate: mirror and motor of tumor malignancy
10.1016/j.semradonc.2004.04.004 · doi-reference
Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts
10.3109/09553000903232868 · doi-reference
Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat
10.1158/0008-5472.can-04-3900 · doi-reference
Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model
10.1016/s0360-3016(01)01700-x · doi-reference
Growth rates or radiobiological hypoxia are not correlated with local metabolite content in human melanoma xenografts with similar vascular network
10.1038/bjc.1995.432 · doi-reference
pO2 fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts
10.1016/j.ijrobp.2011.09.037 · doi-reference
Why do cancers have high aerobic glycolysis?
10.1038/nrc1478 · doi-reference